Clinical Trial Update: Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating topotecan with bevacizumab in stage IIIB/IV non-small cell lung cancer after prior chemotherapy; results completed with posted results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Topotecan (topotecan)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-06-15